日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Exosome-Associated MTA1 in Circulation Is Elevated During Breast Cancer Progression

乳腺癌进展过程中循环中外泌体相关MTA1水平升高

Bhandari, Kritisha; Kong, Jeng Shi; Tanaka, Takemi; Dooley, William C; Xu, Chao; Hannafon, Bethany N; Ding, Wei-Qun

Surgical delay-associated mortality risk varies by subtype in loco-regional breast cancer patients in SEER-Medicare

在SEER-Medicare数据库中,局部区域性乳腺癌患者的手术延迟相关死亡风险因亚型而异。

Leslie Salewon, Macall; Pathak, Rashmi; Dooley, William C; Squires, Ronald A; Rui, Hallgeir; Chervoneva, Inna; Tanaka, Takemi

EWI2 and its relatives in Tetraspanin-enriched membrane domains regulate malignancy

EWI2及其在富含四跨膜蛋白的膜结构域中的同源蛋白调控恶性肿瘤

Ding, Yingjun; Chen, Junxiong; Li, Shuping; Wren, Jonathan D; Bajpai, Akhilesh K; Wang, Jie; Tanaka, Takemi; Rice, Heather C; Hays, Franklin A; Lu, Lu; Zhang, Xin A

Increased breast cancer mortality due to treatment delay and needle biopsy type: a retrospective analysis of SEER-medicare

治疗延误和针刺活检类型导致乳腺癌死亡率上升:SEER-Medicare 回顾性分析

Pathak, Rashmi; Leslie, Macall; Dondapati, Priya; Davis, Rachel; Tanaka, Kenichi; Jett, Elizabeth; Chervoneva, Inna; Tanaka, Takemi

EWI2 prevents EGFR from clustering and endocytosis to reduce tumor cell movement and proliferation

EWI2 可阻止 EGFR 聚集和内吞作用,从而减少肿瘤细胞的运动和增殖。

Fu, Chenying; Wang, Jie; Pallikkuth, Sandeep; Ding, Yingjun; Chen, Junxiong; Wren, Jonathan D; Yang, Yuchao; Wong, Kwong-Kwok; Kameyama, Hiroyasu; Jayaraman, Muralidharan; Munshi, Anupama; Tanaka, Takemi; Lidke, Keith A; Zhang, Xin A

Prolonged Time from Diagnosis to Breast-Conserving Surgery is Associated with Upstaging in Hormone Receptor-Positive Invasive Ductal Breast Carcinoma

从诊断到保乳手术的时间延长与激素受体阳性浸润性导管癌的肿瘤分期升高相关

Hills, Natalie; Leslie, Macall; Davis, Rachel; Crowell, Marielle; Kameyama, Hiroyasu; Rui, Hallgeir; Chervoneva, Inna; Dooley, William; Tanaka, Takemi

Improving vascular maturation using noncoding RNAs increases antitumor effect of chemotherapy

利用非编码RNA促进血管成熟可增强化疗的抗肿瘤效果

Mangala, Lingegowda S; Wang, Hongyu; Jiang, Dahai; Wu, Sherry Y; Somasunderam, Anoma; Volk, David E; Lokesh, Ganesh L R; Li, Xin; Pradeep, Sunila; Yang, Xianbin; Haemmerle, Monika; Rodriguez-Aguayo, Cristian; Nagaraja, Archana S; Rupaimoole, Rajesha; Bayraktar, Emine; Bayraktar, Recep; Li, Li; Tanaka, Takemi; Hu, Wei; Ivan, Cristina; Gharpure, Kshipra M; McGuire, Michael H; Thiviyanathan, Varatharasa; Zhang, Xinna; Maiti, Sourindra N; Bulayeva, Nataliya; Choi, Hyun-Jin; Dorniak, Piotr L; Cooper, Laurence Jn; Rosenblatt, Kevin P; Lopez-Berestein, Gabriel; Gorenstein, David G; Sood, Anil K

Aptamer Therapeutics in Cancer: Current and Future

癌症适体疗法:现状与未来

Morita, Yoshihiro; Leslie, Macall; Kameyama, Hiroyasu; Volk, David E; Tanaka, Takemi

Fibroblast growth factor-2 (FGF2) and syndecan-1 (SDC1) are potential biomarkers for putative circulating CD15+/CD30+ cells in poor outcome Hodgkin lymphoma patients

成纤维细胞生长因子-2 (FGF2) 和聚糖蛋白-1 (SDC1) 是预后不良的霍奇金淋巴瘤患者中循环 CD15+/CD30+ 细胞的潜在生物标志物

Gharbaran, Rajendra; Goy, Andre; Tanaka, Takemi; Park, Jongwhan; Kim, Chris; Hasan, Nafis; Vemulapalli, Swathi; Sarojini, Sreeja; Tuluc, Madalina; Nalley, Kip; Bhattacharyya, Pritish; Pecora, Andrew; Suh, K Stephen

Prolactin-Stat5 signaling in breast cancer is potently disrupted by acidosis within the tumor microenvironment

乳腺癌中催乳素-Stat5信号通路在肿瘤微环境中受到酸中毒的强烈干扰。

Yang, Ning; Liu, Chengbao; Peck, Amy R; Girondo, Melanie A; Yanac, Alicia F; Tran, Thai H; Utama, Fransiscus E; Tanaka, Takemi; Freydin, Boris; Chervoneva, Inna; Hyslop, Terry; Kovatich, Albert J; Hooke, Jeffrey A; Shriver, Craig D; Rui, Hallgeir